Previous Close | 43.79 |
Open | 43.79 |
Bid | 0.00 x 3200 |
Ask | 0.00 x 1300 |
Day's Range | 43.40 - 44.13 |
52 Week Range | 41.45 - 56.32 |
Volume | |
Avg. Volume | 21,520,290 |
Market Cap | 244.44B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | 25.51 |
EPS (TTM) | 1.71 |
Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
Forward Dividend & Yield | 1.60 (3.51%) |
Ex-Dividend Date | Nov 03, 2022 |
1y Target Est | N/A |
The decentralized autonomous organization is raising funds for research on technologies that target human aging.
The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.
Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.